Latin America Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Reporter.

Press releases published on September 10, 2026

Sep. 10, 2026

Chef Grecia Ramos: The Pastry Chef Redefining Dessert in Texas Barbecue

Indeterminate EIN Presswire

Sep. 10, 2026

ダークホース・コンサルティング・グループ、上海オフィスの開設を記念してテープカット式典を開催

Indeterminate GlobeNewswire

Sep. 10, 2026

Dark Horse Consulting Group 举行剪彩仪式，庆祝上海办公室开业

Indeterminate GlobeNewswire

Sep. 10, 2026

Dark Horse Consulting Group 舉行剪綵儀式，標誌其上海辦事處正式開業

Indeterminate GlobeNewswire

Sep. 10, 2026

Dark Horse Consulting Group, 리본 커팅 행사 열고 상하이 사무소 공식 개소

Indeterminate GlobeNewswire

Sep. 10, 2026

Dark Horse Consulting Group Meraikan Pembukaan Pejabat Baharu di Shanghai dengan Upacara Pemotongan Reben

Indeterminate GlobeNewswire

Sep. 10, 2026

Outlook Therapeutics CEO, Bob Jahr, Discusses FDA Approval and Commercial Opportunity for LYTENAVA™ in Virtual Investor CEO Connect Segment

Indeterminate GlobeNewswire

Sep. 10, 2026

Canada Steps Up to Support Global Cancer Care with First Contribution to IAEA’s Rays of Hope Initiative

Indeterminate GlobeNewswire

Sep. 10, 2026

Lite Strategy to Present at the 28th Annual H.C. Wainwright Global Investment Conference in New York

Indeterminate GlobeNewswire

Sep. 10, 2026

Fortrea to Participate in September Investor Conferences

Indeterminate GlobeNewswire

Sep. 10, 2026

Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU

Indeterminate GlobeNewswire

Sep. 10, 2026

Vistagen to Present at Psych Congress 2026

Indeterminate GlobeNewswire

Sep. 10, 2026

Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer

Indeterminate GlobeNewswire

Sep. 10, 2026

ORYZON to Participate in Upcoming Events in September and October

Indeterminate GlobeNewswire

Sep. 10, 2026

Electra Therapeutics Announces Initiation of a Phase 1 Trial of ELA822, a Novel SIRPγ-Specific Antibody Designed to Treat T Cell-Mediated Immune and Inflammatory Diseases

Indeterminate GlobeNewswire

Sep. 10, 2026

Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting

Indeterminate GlobeNewswire

Sep. 10, 2026

Aprea Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 10, 2026

SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 10, 2026

Novacium and Tokai COBEX Collaborate to Evaluate an Integrated and Sovereign European Anode Material Solution for Lithium-Ion Batteries

Indeterminate GlobeNewswire

Sep. 10, 2026

Novacium et Tokai COBEX collaborent à l’évaluation d’une solution européenne intégrée et souveraine de matériaux d’anode pour batteries lithium-ion

Indeterminate GlobeNewswire